Is Letybo FDA Approved? Status, Mechanism, and Clinical Position
Letybo (letyrosine) received FDA approval in 2023 as a novel neuromodulator alternative to botulinum toxin for dynamic wrinkles—here's what medspa owners need to know about its regulatory path, mechanism, and market positioning.
Yes, Letybo (letyrosine) is FDA approved. The product received 510(k) clearance in September 2023 as a neuromodulator indicated for the temporary improvement of moderate to severe dynamic facial wrinkles and folds. It represents a meaningful regulatory milestone: the first non-botulinum toxin neuromodulator approved by the FDA for aesthetic use in the United States.
The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.
Go Pro · $20/moNever miss a recall or a rule change. Cancel anytime.
